Medicine. A portfolio model of drug development for tuberculosis.
Glickman
Seth W
SW
Health Sector Management Program, Fuqua School of Business, Duke University, Durham, NC 27708, USA.
Rasiel
Emma B
EB
Hamilton
Carol Dukes
CD
Kubataev
Arsen
A
Schulman
Kevin A
KA
D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000191:economics; D003198:Computer Simulation; D003365:Costs and Cost Analysis; D017277:Drug Approval / Q000191:economics; D004353:Drug Evaluation, Preclinical / Q000191:economics; D004345:Drug Industry; D006801:Humans; D009010:Monte Carlo Method; D009316:National Institutes of Health (U.S.); D017149:Private Sector; D011336:Probability; D017150:Public Sector; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D014481:United States
D000995:Antitubercular Agents